Literature DB >> 2581569

Binding of alpha 2-macroglobulin to hepatocytes: mechanism of in vivo clearance.

S R Feldman, M R Rosenberg, K A Ney, G Michalopoulos, S V Pizzo.   

Abstract

The binding of 125I-labeled human alpha 2-macroglobulin-methylamine to adult rat hepatocytes in primary culture was studied at 4 degrees C. Cells which had been in culture for 4 hours exhibited steady state ligand binding after 1 hour, a receptor number of 22,400 receptors per cell, and a dissociation constant of 0.6 nM. Adult rat hepatocytes exhibited a significant decrease in receptor number with increased time in primary culture with less than 10% of the initial number of receptors remaining after 2 days (p less than 0.01). In autopsy studies of mice injected intravenously with 125I-labeled alpha 2-macroglobulin-methylamine, greater than 90% of the cleared ligand was found in the liver. Autoradiography of the liver demonstrated that 80% of the ligand was cleared by hepatocytes. It is concluded that the hepatocytes are the primary pathway for clearance from the circulation of receptor recognized alpha 2-macroglobulin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581569     DOI: 10.1016/0006-291x(85)90117-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.

Authors:  M C van Dijk; G J Ziere; W Boers; C Linthorst; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Model of alpha 2-macroglobulin structure and function.

Authors:  S R Feldman; S L Gonias; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.

Authors:  I Tchetverikov; L S Lohmander; N Verzijl; T W J Huizinga; J M TeKoppele; R Hanemaaijer; J DeGroot
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

4.  Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site.

Authors:  S V Pizzo; P A Roche; S R Feldman; S L Gonias
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

5.  Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.

Authors:  L M Wakefield; T S Winokur; R S Hollands; K Christopherson; A D Levinson; M B Sporn
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation.

Authors:  S L Pender; P Lionetti; S H Murch; N Wathan; T T MacDonald
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Evidence for an alpha 2-macroglobulin with complement-inhibiting activity in rat serum.

Authors:  R Bellott; A Bon; J Lestage; J P Giroud; P Chateaureynaud
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

8.  Role of the scavenger receptor in the uptake of methylamine-activated alpha 2-macroglobulin by rat liver.

Authors:  M C van Dijk; W Boers; C Linthorst; T J van Berkel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

9.  Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor.

Authors:  G C Howard; U K Misra; D L DeCamp; S V Pizzo
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

10.  Incorporation of low molecular weight molecules into alpha(2)-macroglobulin by nucleophilic exchange.

Authors:  Jennifer E Bond; George J Cianciolo; Salvatore V Pizzo
Journal:  Biochem Biophys Res Commun       Date:  2007-04-02       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.